Neumora Therapeutics, Inc. (NMRA) Q3 2024 Earnings Report

446 Followers

NMRA Q3 2024 EPS Results

Actual EPS-$0.45

Consensus EPS-$0.39

Beat/MissMissed by -$0.06

One Year Ago EPS-$1.14

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ3 2024

Date11/12/2024

TimeBefore Open

Conference CallTuesday, November 12, 2024

NMRA Upcoming Earnings

Neumora Therapeutics, Inc.'s next earnings date is estimated for November 4, 2026, based on past reporting schedules.

NMRA Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	-0.20 / -	-0.35	―
Aug 14, 2026	2026 (Q2)	-0.24 / -0.23	-0.33	30.30% (+0.10)
May 07, 2026	2026 (Q1)	-0.32 / -0.30	-0.42	28.57% (+0.12)
Mar 30, 2026	2025 (Q4)	-0.33 / -0.35	-0.37	5.41% (+0.02)
Nov 06, 2025	2025 (Q3)	-0.33 / -0.35	-0.45	22.22% (+0.10)
Aug 06, 2025	2025 (Q2)	-0.36 / -0.33	-0.37	10.81% (+0.04)
May 12, 2025	2025 (Q1)	-0.37 / -0.42	-0.34	-23.53% (-0.08)
Mar 03, 2025	2024 (Q4)	-0.42 / -0.37	-0.71	47.89% (+0.34)
Nov 12, 2024	2024 (Q3)	-0.39 / -0.45	-1.14	60.53% (+0.69)
Aug 06, 2024	2024 (Q2)	-0.37 / -0.37	-0.278	-33.09% (-0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed